Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05534061 · ClinicalTrials.gov registry record · NA
Motivation, Syringe Exchange, and COVID-19
A NA study, sponsored by University of Oregon.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT05534061 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 349 participants.
The verdict
NCT05534061, a NA study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
People who inject drugs (PWIDs) are highly vulnerable to SARS-CoV-2 infection and to the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), however, rates of SARS-CoV-2 testing and vaccination uptake -vital to mitigating the spread of COVID-19 and achieving herd immunity - are lower among PWIDs compared to the general population. Building on our Phase I Rapid Acceleration of Diagnostics project, which found that contingency management (CM) increased testing utilization among PWIDs, the proposed project evaluates the comparative effectiveness of CM versus CM plus a brief motivational enhancement intervention on SARS-CoV-2 testing and vaccination uptake among PWIDs. This project has the potential to reduce COVID-19 health disparities among PWIDs and to decrease population level COVID-19 morbidity and mortality.
Interventions
- BEHAVIORAL Connect2Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2022-08-08 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05534061
The ClinicalTrials.gov registry entry for NCT05534061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oregon, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Connect2Test is the first listed.
NCT05534061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05534061 about?
NCT05534061 is a clinical study titled "Motivation, Syringe Exchange, and COVID-19". People who inject drugs (PWIDs) are highly vulnerable to SARS-CoV-2 infection and to the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), however, rates of SARS-CoV-2 testing and vaccination uptake -vital to mitigating the spread of COVID-19 and achieving herd immunity - are lower ...
What is the current status of trial NCT05534061?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2022-08-08. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05534061?
The interventions under investigation include: Connect2Test (BEHAVIORAL).
Who is sponsoring clinical trial NCT05534061?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.